Status:
COMPLETED
Oesophageal Probe Evaluation in RF Ablation of Atrial Fibrillation
Lead Sponsor:
Heart Center Leipzig - University Hospital
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The Trial will evaluate the influence of oesophageal probes in Radio frequency (RF)-ablation of atrial fibrillation regarding oesophageal ulcers after ablation.
Detailed Description
The Trial will evaluate the influence of oesophageal probes in RF-ablation of atrial fibrillation regarding oesophageal complications after ablation. 200 patients will be prospectively randomised int...
Eligibility Criteria
Inclusion
- 12 lead ECG with documented atrial fibrillation
- Indication for RF ablation of atrial fibrillation according to the recent guidelines
- Signed informed consent
- Age 18-85 years
Exclusion
- Pregnancy or possible pregnancy without negative test within 48h prior to ablation
- Intracardiac thrombus
- Contraindication for oral anticoagulation
- Conditions, that may complicate the positioning of the oesophageal probe
Key Trial Info
Start Date :
July 3 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 24 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03246594
Start Date
July 3 2017
End Date
October 24 2019
Last Update
May 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Heart Center Leipzig
Leipzig, Germany, 04289